Financials
Financial year 2025
AG PHARMA CONSULT from Sint-Genesius-Rode, company number BE0831429560, closed financial year 2025 with a result of € 19,089 after tax. For that financial year AG PHARMA CONSULT recorded a gross margin of € 22,011 and equity of € 10,176. Compared with financial year 2024, the result moved from € -6,129 to € 19,089. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on May 5, 2026.
€ 10,176
▲ € 19,089 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 19,089
▲ still € 6,129 loss in 2024
Profit after tax over the fiscal year.
€ 47,541
▲ € 39,607 vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -8,424.
People and assets in 2025
€ 1,945
▲ 48% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 5,021
▲ € 4,869 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 22,271
▲ € 22,094 vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 15,924 | € -63,751 | € 5,527 | € 22,011 | ▲ 298% |
| Profit after taxes | € 19,128 | € -89,718 | € -6,129 | € 19,089 | ▲ € 25,218 |
| Equity | € 86,934 | € -2,784 | € -8,913 | € 10,176 | ▲ € 19,089 |
| Total debts | € 31,165 | € 10,901 | € 18,556 | € 40,007 | ▲ 116% |
| Cash | € 45,125 | € 4,524 | € 7,935 | € 47,541 | ▲ € 39,607 |
| Retained profit | € 68,334 | € -21,384 | € -27,513 | € -8,424 | ▲ € 19,089 |
| Bank debt | € 16,667 | € 0 | € 0 | € 0 | |
| Balance sheet total | € 118,099 | € 8,117 | € 9,643 | € 50,183 | ▲ € 40,540 |
Key figures of AG PHARMA CONSULT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.
What happened to AG PHARMA CONSULT?
What happened at AG PHARMA CONSULT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 19,089. filed late Source: NBB ↗
- New establishment in Sint-Genesius-Rode. KBO
- A GUYOT became a director. NBB
- Corinne RENAULT became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 19,128 profit in 2022 to € 19,089 profit in 2025.
Paid € 12,689 in corporate taxes since 2022.
Best year ever: 2022, with € 19,128 profit.
A new publication or filing at AG PHARMA CONSULT? We notify you, reason included.
Follow AG PHARMA CONSULTDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind AG PHARMA CONSULT are A GUYOT and Corinne RENAULT.
Directors
According to the 2025 annual accounts
A GUYOT
Director
since 2010
Corinne RENAULT
Director
since 2010
Establishments
Establishment units
Physical locations of this company
Stationsstraat 71
1640 Sint-Genesius-Rode
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0831.429.560
- VAT number
- BE 0831.429.560
- Registered office
- Stationsstraat 71, 1640 Sint-Genesius-Rode
- Names & denominations
- AG PHARMA CONSULT
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 23 November 2010
- Peppol
- Active · Active since 15 Jul 2025
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van public relations en communicatie
Adviesbureaus op het gebied van public relations en communicatie
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering